Treatment with the insulin analogue lispro in children and adolescents with Type 1 diabetes mellitus: Evaluation over a 3-year period

Diabetes, Nutrition and Metabolism - Clinical and Experimental

Volumn 15, Issue 1, 2002, Pages 7-13

  Garcia L ^a   Lamas, C ^a   Tuset, M J ^a   Alonso, M ^a   Barrio, R ^a  

^a NONE   (Spain)

Author keywords

Diabetes in paediatric age; Glycosilated haemoglobin; Hypoglicaemia; Insulin analogue; Lispro; Type 1 diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN; INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN;

ADOLESCENT; ARTICLE; BODY MASS; CARBOHYDRATE INTAKE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE DURATION; DISEASE SEVERITY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG FORMULATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE DIABETES MELLITUS; LIPID METABOLISM; MALE; METABOLIC REGULATION; MORBIDITY; PRIORITY JOURNAL; SELF REPORT;

ADOLESCENT; CHILD; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; PROSPECTIVE STUDIES;

EID: 0036118453     PISSN: 03943402     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. The effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus: The Diabetes Control and Complications Trial
2. Implications and results of the Diabetes Control and Complications Trial
3. Health-related quality-of-life results from multinational clinical trials of insulin lispro: Assessing benefits of a new diabetes therapy
4. Comparative study of insulin lispro and regular insulin in 481 adolescents with type 1 diabetes
5. Tratamiento con insulina Lispro (Lys B28, Pro B29) en adolescentes y jóvenes con diabetes mellitus tipo 1
6. Improvements of blood glucose control in Type 1 diabetic patients treated with lispro and multiple NPH injections
7. Insulin analogs and their potential in the management of diabetes mellitus
8. Timing of pre-meal insulins in diabetic patients on a multiple daily injection regimen. A questionaire study
9. The effect of the insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients
10. Lispro or regular insulin for multiple injection therapy in adolescence
11. Effect of the fast-acting insulin analog lispro on the risk of nocturnal hypoglycemia during intensified insulin therapy
12. Pre-meal insulin analogue insulin lispro vs Humulin R insulin treatment in young subjects with type 1 diabetes
13. Meta-analysis of the effect of insulin lispro on severe hypoglycemia in patients with type 1 diabetes
14. 2-year prospective audit of the effect of the introduction of insulin lispro in patients with specific clinical indications
15. Use of the short-acting insulin analog in intensive treatment of type 1 diabetes mellitus: Importance of appropriate replacement of basal insulin and time-interval injection-meal
16. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime
17. Postprandial glycemia after administration of regular insulin and insulin lispro to children and adolescents with diabetes
18. Effectiveness of postprandial Humalog in toddles with diabetes
19. Comparative study of insulin lispro and regular insulin in prepubertal children with type 1 diabetes
20. Long term efficacy of Humalog in subjects with type 1 diabetes mellitus
21. Optimization of evening insulin dose in patients using the short acting insulin analog lispro
22. Insulin lispro in CSII: Results of a double-blind crossover study
23. Strategies toward improved control during insulin lispro therapy in IDDM. Importance of basal insulin
24. Use of insulin lispro in pediatric patients with IDDM
25. Lispro insulin as premeal therapy in type 1 diabetes: Comparison with humulin regular
26. Insulin analogues
27. The human insulin analogue insulin lispro
28. Effects of the short acting insulin analog (Lys(B28), Pro(B29)) on postprandial blood glucose control in IDDM
29. Early preprandial hypoglycemia after administration of insulin lispro
30. Reducing snacks when switching from conventional soluble to lispro insulin treatment: Effects on glycemic control and hypoglycemia
31. Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin analog treatment
32. Insulin lispro (LP) results in less nocturnal hypoglicemia compared with human insulin in adolescents with type 1 diabetes
33. The effect of insulin analog lispro on nighttime blood glucose control in type 1 diabetic patients
34. Effect of continous subcutaneous insulin infusion with lispro on hepatic responsiveness to glucagon in type 1 diabetes
35. Clinical studies on insulin lispro
36. Treatment with insulin lispro (Lys B28 Pro B29) in adolescents with diabetes type 1
37. Three years experience in the treatment of diabetic adolescents with Humalog